SIGNAL
Mpox is no longer emerging or retreating. It has settled into a durable post-smallpox niche, and every new cluster is the same virus reading the same room.
The default reading of Guinea-Bissau's first known outbreak, 10 confirmed cases in August 2026 with no clear links between them, is a curiosity. The default reading of the 2022 global wave was a contained outbreak. Both miss the mechanism. When smallpox vaccination ended in 1980, the world's orthopoxvirus immunity shelf emptied with it. Mpox, a close-contact cousin that spreads through lesions, skin, sexual contact, and household clusters, walked into the shelf and stayed.
The standing-risk anchor, per WHO, is 187,117 laboratory-confirmed mpox cases and 510 deaths across 145 countries between January 2022 and May 31, 2026. That is about 0.3 percent reported case-fatality, and almost certainly an undercount, because the outbreaks cluster in the same West African surveillance gaps where detection has always been thin.
Two WHO public-health emergencies of international concern have now been declared on this virus and lapsed. That is the falsifier, not the reassurance. The emergency cycle treats mpox as a wave to be broken. The phylogenetics, clade IIb lineages linking Guinea-Bissau's viruses to Sierra Leone, Guinea, and Nigeria, treat it as ongoing circulation that survives every wave. A known virus, a known transmission ecology, a known immunity gap, a known surveillance deficit. Guinea-Bissau is not a new disease. It is a familiar one, finally being counted.
Reported by Sky for Type0, from Mpox Keeps Coming Back and Scientists Are Starting to Understand Why. Read the original: zmescience.com